ClinicalTrials.gg
CompletedNCT05783050Updated Aug 12, 2024

Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support in Gastrointestinal Endoscopy Patients

An interventional study of Wei Nasal Jet Tube and Nasal Cannula Oxygen Support in Supraglottic Airway Obstruction, Airway Complication of Anesthesia and Airway Obstruction, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-12.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Sedoanalgesia is applied to patients during gastrointestinal endoscopy. Sedoanalgesia may cause respiratory depression and hypoxia in patients. During these procedures, patients should be given oxygen support to reduce the incidence of hypoxia.This study aimed to compare the efficacy and procedural performance of two different airway devices (Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support) in Gastrointestinal Endoscopy

Read the detailed description

Gastrointestinal endoscopy is performed as standard for the diagnosis of many gastrointestinal diseases. During gastrointestinal endoscopy, sedoanalgesia is applied to relieve patients' pain and increase patient comfort. Anesthetic drugs used for sedoanalgesia may cause respiratory depression and hypoxia in patients. Hypoxia resulting from hypoventilation in patients is responsible for many events, including coronary ischemia. During these procedures, patients should be given oxygen support to reduce the incidence of hypoxia. The purpose of this procedure is to provide safe oxygenation and ventilation. While providing oxygen support, nasal cannula, classical oxygen mask can be used, as well as new generation oxygenation devices. Our study will show us which method is more beneficial in preventing hypoxia and other side effects, providing comfort for the doctor performing the procedure and for the patient undergoing the procedure. This study aimed to compare the efficacy and procedural performance of two different airway devices (Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support) in Gastrointestinal Endoscopy

02

Conditions studied

  • Supraglottic Airway Obstruction
  • Airway Complication of Anesthesia
  • Airway Obstruction
  • Anesthesia Complication
  • Bronchospasm
  • Nasal Bleeding
  • Oxygen Deficiency

Keywords

  • Wei Nasal Jet Tube
  • Airway Complication
  • Nasal Cannula Oxygen Support
  • Gastrointestinal Endoscopy
  • sedation
03

In context

Airway Obstruction

147 studies on the registry are indexed under Airway Obstruction; 25 are open to participants now.

This study's enrollment of 100 is above the median of 53 across 92 interventional studies indexed under Airway Obstruction.

Browse Airway Obstruction studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 354 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing gastrointestinal endoscopy
  • ASA Physical Status 1-2
  • 18.5 - 35 kg/m2

Exclusion criteria

Exclusion Criteria:

  • High risk of pulmonary aspiration

    • Pregnancy
    • Anesthesic drug allergies
    • Difficult airway or facial deformities
    • Height \<155 cm
    • Alcohol or narcotic drug usage
    • Restrictive or obstructive pulmonary diseases
    • Hepatic cardiac or renal failure
    • Neurologic or cognitive deficiencies.
    • Previous cervical surgery or cervical radiotherapy
    • Previous esophagus surgery
    • Psychotic problems
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (actual)

Study arms

  • Active comparator
    Wei Nasal Jet Tube Group (Group W)

    After induction of anesthesia, the Wei Nasal Jet Tube was placed in the patients.

    Device: Wei Nasal Jet Tube

  • Active comparator
    Nasal Cannula Oxygen Support Group (Group N)

    After the induction of anesthesia, the Nasal Cannula Oxygen Cannula was placed in the patients.

    Device: Nasal Cannula Oxygen Support

Interventions

  • DeviceWei Nasal Jet Tube

    The purpose of this procedure is to provide safe oxygenation and ventilation. While providing oxygen support, nasal cannula, classical oxygen mask can be used, as well as new generation oxygenation devices.

  • DeviceNasal Cannula Oxygen Support

    The purpose of this procedure is to provide safe oxygenation and ventilation. While providing oxygen support, nasal cannula, classical oxygen mask can be used, as well as new generation oxygenation devices.

06

What researchers measure

Primary outcomes

  1. Hypoxia incidence

    Hypoxia is defined as SpO2 \<92% at any time.

    Time frame: Intra-operative; after device insertion

Secondary outcomes

  1. Airway assist maneuver required

    When the SpO2 value is below 90-92%, airway support maneuvers will be performed

    Time frame: Intra-operative; after device insertion

  2. Procedure failure incidence

    The development of severe hypotension (MAP \<55 mmHG), bradycardia ( HR\< 45 bpm) and prolonged deep hypoxia(\>60 sec SpO2\<92%) during procedure

    Time frame: Intra-operative; after device insertion

07

Study locations

1 site
  • Bezmialem Vakif University
    Istanbul, Turkey
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Jun 2023, 2 months.

Of 36 non-industry interventional studies with no phase under Airway Obstruction, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 37. This study's 2 months is below that.

Counting every sponsor, half of 44 studies reached it within 16 months; a quarter within 3 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2023
First posted
Mar 24, 2023
StartActual
Mar 30, 2023
Primary completionActual
Jun 15, 2023
CompletionActual
Jul 1, 2023
Last update
Aug 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05783050
Responsible party
İsmail SÜMER (Principal Investigator, Bezmialem Vakif University) — Principal investigator
First posted
Mar 24, 2023
Start date
Mar 30, 2023
Primary completion
Jun 15, 2023
Completion
Jul 1, 2023
Last update
Aug 12, 2024

Study contacts

ISMAIL SUMER, MD
principal investigator · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion